CK Group are recruiting for a PK/PD Scientist(Post-Doctoral) to join a companyin the pharmaceutical industry at their site based in Bracknell ona contract basis for 12 months (potential to extend).
Salary:
£21.22-£26.52 p/h PAYE.
PK/ PD Scientist(Post-Doctoral) Role:
* Therole requires exceptional research and communication abilities toplay an essential role in high-impact research endeavours spanningfrom discovery to advanced clinical development of Antibody Drugconjugates (ADC).
* Elish the appropriate doseand regimen to achieve better theutic index and understand thepreliminary dosing requirements.
* Elish acomprehensive and flexible framework (Clinical Utility Index) formodelling ADC PKPD and the Exposure-Response relationship in bothpreclinical and clinical settings.
* Develop acellular mathematical model with a deep understanding ofphysiochemical properties, the range of affinities that arecompatible with the target product profile for each ADC target, andthe mechanism of action of ADC components (mAb, linker and payloadand conjugated ADCs).
YourBackground:
* PhD inPharmacometrics, Pharmaceutical/Biomedical Sciences, ComputationalSciences, Engineering, or a relateddiscipline.
* Experience using relevant softwaresuch as R, Monolix, NONMEM, MATLAB, orsimilar.
* Experience in QSP, PK/PD,exposure-response modeling or other modelling & simulationrelated discipline.
* Understanding ofpharmacokinetics and/or pharmacodynamicprinciples.
* Proficient in data ysis andreporting.
Company:
Our client is oneof the largest pharmaceutical companies in the world. They focus onfinding answers for some of the world's most urgent medicalneeds.
Location:
This role is basedat our clients site in Bracknell. This is a hybrid role with officepresence required two times per week.
Apply:
For more information,or to apply for this PK/ PD Scientist (Post-Doctoral) role pleasecontact the Key Accounts Team onor email Please quote reference107452.
Itis essential that applicants hold entitlement to work in theUK
Pleasenote:
This role may be subject to asatisfactory basic Disclosure and Barring Service (DBS)check.